| Identification | Back Directory | [Name]
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) | [CAS]
2647975-06-0 | [Synonyms]
SSAO/VAP-1 inhibitor 1
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) | [Molecular Formula]
C16H22ClFN2O3 | [MOL File]
2647975-06-0.mol | [Molecular Weight]
344.81 |
| Hazard Information | Back Directory | [Uses]
SSAO/VAP-1 inhibitor 1 is a potent inhibitor of SSAO/VAP-1. SSAO/VAP-1 promotes the transfer of Glucose transport 4 (GLUT 4) from adipocytes to the cell membrane, thereby regulating glucose transport. In endothelial cells, SSAO/VAP-1 can mediate the adhesion and exudation of leukocytes and endothelial cells, and participate in inflammatory responses. SSAO/VAP-1 inhibitor 1 has the potential for the research of inflammation and/or inflammation-related disease or diabetes and/or diabetes-related disease (extracted from patent WO2021102774A1, compound E3)[1]. | [References]
[1] Zhen Gu, et al. A kind of amine derivative as ssao/vap-1 inhibitor and use thereof. Patent WO2021102774A1. |
|
|